SNPS (Synopsys)
All Pro Portfolios with SNPS

People owning SNPS also tend to own:: ASMLCYMIKLACMFESTXSYMCMSFT

All Do-It-Yourself Portfolios with SNPS
  • News For Selected Stock
  • Related stories on theStreet.com
  • videos related to etf's
  • No videos found
  •  
  • blogs related to etf's
  • No blogs found
  •  

Why I Love This Stock

By:barrons3

Date:10 25 08

Synopsys (SNPS) has won over Paul Wick, managing partner of J&W Seligman and head of Seligman Technology Group. "This is one of the most disruptive tech markets I've ever seen," says Wick, who pioneered tech mutual funds. But the disruption can produce opportunities like Synopsys, whose share price has fallen from 28 to 16. It makes software used to design electronic items like semiconductors. For all the fear about consumers, Wick doesn't believe the end buyer of Synopsys' clients' goods is in too bad shape. Adds Wick, "This is the ultimate defensive stock to the consumer electronics and computer industry." About 90% of Synopsys' revenue comes from a "visible" backlog of orders, which alleviates some pressure on 2008 sales. He believes Synopsys' earnings will grow 10% to 20% a year over the next three to five years as profit margins swell to 25% in 2009 from 23.5% this year. He thinks the Street's consensus earnings-per-share estimate of $1.67 is too low; he looks for $1.90 a share. The stock, says Wick, has the potential to hit 21. And with $6 a share in cash, he doesn't understand why more value investors haven't hopped on board yet.

Not yet rated
Rate now:

By:barrons2

Date:12 15 07

Synopsys (SNPS), he says, has been beating numbers and raising guidance, but the stock has gone nowhere.

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

Synopsys (SNPS) was upgraded from Hold to Buy, Deutsche Bank said. $32 price target. Company posted a strong quarter, and margins and operating cash flow should continue to grow. Estimates also raised.

Not yet rated
Rate now:

By:barrons2

Date:10 06 07

His biggest position is Synopsys (SNPS), maker of electronic-design-automation software; he notes that it recently signed its biggest deal ever, a five-year, $500 million pact with Intel. Synopsys has 90% recurring revenue. As a result, he contends, it's unlikely ever to blow up.

Not yet rated
Rate now:

By:anur0

Date:09 28 07

Unbelievable margin leverage in 08

Not yet rated
Rate now:

By:rbruce97520

Date:08 10 07

own

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

Downgraded by HSBC Securities from Overweight to Neutral

Not yet rated
Rate now:

By:Barrons

Date:03 10 07

The company is a clear leader in a strong field, and its stock, thanks in part to the recent drubbing of tech shares, looks ripe for the buying.

Says Yang Lie of Third Avenue Funds: "This is a very well financed company." Another big investor thinks it's worth at least 25% more than the current stock price.

Not yet rated
Rate now:

By:Guest

Date:11 30 -1

Predictable revenue and improving operating margin

Not yet rated
Rate now:

Why I Hate This Stock

Comments not available
Add Your Comments  
Stock SNPS
Allowed HTML tags: <a><b><i><img>
  Login to post your comments
Four Must-See Charts: Stem Cell ...

By Stockpickr Staff Posted on July 2, 2009 Developments in the stem cell world are starting to get very interesting. On Tuesday, General Electric (GE) signed an exc...

07.02.09 | 15:19 PM
Stockpickr's Picks of the Day: J...

By Rebecca Corvino Posted on July 2, 2009 Every day, Stockpickr members are creating and sharing stock ideas with each other through various platforms. If you're not al...

07.02.09 | 13:43 PM
Cramer's Take on Headline Stocks...

By Rebecca Corvino Posted at 12:30 p.m. EDT on July 2, 2009 Making Thursday's headlines and sending stocks lower were reports that June saw the loss of 467,000 more job...

07.02.09 | 12:31 PM
Dividend Stocks for the Week

By Stockpickr Staff Posted on July 2, 2009 Some investors assume that at this time of year, it's the summer doldrums for the stock market. After all, as the saying goe...

07.02.09 | 11:02 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
what happened to DSCO?
07.02.09 | 11:45 AM From author Disco Duck
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
more forums
Q. hgsi lupus drug. results on jul...
07.03.09 | 23:42 PM Asked by 1surfer2

A. the data seems really positive ... I
just read through BioMedReports and
thought it was impressive - the largest
lupus trial ever.

today 's lists
Rising on Unusual Volume

Here are some stocks that moved up on unusual volume on July 1, 2009. more

Latest Activist Situations

Here are the latest Activist or "13D" situations from the StreetInsider.com 13D Tracker page found at: http://www.13dtracker.blogspot.com/.... more

Stocks With Unusual Option Activity

Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more